EX-FILING FEES 7 ea020790501ex-fee_bionomics.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-1

(Form Type)

 

Bionomics Limited

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

    Security Type   Security
Class
 Title(1)  		   Fee
Calculation
Rule  		     Amount
Registered(2)		     Proposed
 Maximum
Offering
Price Per
 Unit(3)  		     Maximum
Aggregate
 Offering
Price(3)  		     Fee
Rate  		     Amount of
Registration
Fee  		  
Fees to Be Paid   Equity   Ordinary Shares, as represented by American Depositary Shares     457 (c)     233,367,480     $ 0.004361389     $ 1,017,806.33     $ 0.00014760     $ 150.23  
Fees to Be Paid   Equity   Ordinary shares underlying the American Depositary Shares issuable upon exercise of accompanying warrants     457 (c)     2,277,462,960     $ 0.004361389     $ 9,932,901.65     $ 0.00014760     $ 1,466.10  
Fees to Be Paid   Equity   Ordinary shares underlying the American Depositary Shares issuable upon exercise of pre-funded warrants     457 (c)     1,130,382,900     $ 0.004361389     $ 4,930,039.42     $ 0.00014760     $ 727.67  
    Total Offering Amounts              $ 15,880,747.40             $ 2,344.00  
    Total Fee Offsets                             $ 0  
    Net Fee Due                               $ 2,344.00  

 

(1) American Depositary Shares, or ADSs, each representing one hundred and eighty ordinary shares, issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 filed on December 10, 2021 (File No. 333-261582).

 

(2) Pursuant to Rule 416 under the Securities Act of 1933, this registration statement includes an indeterminate number of additional shares that may be offered and sold to prevent dilution resulting from share splits, share dividends, recapitalizations or similar transactions.
   
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the average of the high and low sale prices of the registrant’s ADSs on the Nasdaq Global Market on June 13, 2024, or $0.78505, divided by 180 (to give effect to the 180:1 ratio of ordinary shares to ADSs).